Smith & Nephew SNATS ROA 2010-2024 | SNN
Smith & Nephew SNATS ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2014-12-31 | $0.50B | $7.31B | 7.00% |
2014-09-30 | $0.50B | $7.65B | 7.41% |
2014-06-30 | $0.52B | $7.74B | 8.35% |
2014-03-31 | $0.56B | $5.94B | 9.89% |
2013-12-31 | $0.56B | $5.82B | 9.97% |
2013-09-30 | $0.54B | $5.57B | 9.69% |
2013-06-30 | $0.55B | $5.45B | 10.17% |
2013-03-31 | $0.71B | $5.47B | 13.60% |
2012-12-31 | $0.73B | $5.64B | 14.34% |
2012-09-30 | $0.73B | $5.00B | 14.96% |
2012-06-30 | $0.73B | $4.81B | 15.07% |
2012-03-31 | $0.59B | $4.88B | 12.13% |
2011-12-31 | $0.58B | $4.75B | 12.08% |
2011-09-30 | $0.62B | $4.82B | 12.96% |
2011-06-30 | $0.63B | $4.91B | 13.01% |
2011-03-31 | $0.61B | $4.79B | 12.90% |
2010-12-31 | $0.62B | $4.73B | 13.13% |
2010-09-30 | $0.56B | $4.88B | 12.09% |
2010-06-30 | $0.55B | $4.58B | 12.06% |
2010-03-31 | $0.53B | $4.54B | 11.69% |
2009-12-31 | $0.47B | $4.57B | 10.48% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $12.872B | $5.810B |
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $235.957B | 28.37 |
Boston Scientific (BSX) | United States | $147.560B | 36.94 |
Stryker (SYK) | United States | $144.011B | 30.11 |
EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
Medtronic (MDT) | Ireland | $111.928B | 15.87 |
Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
Haleon (HLN) | United Kingdom | $48.904B | 27.87 |
ResMed (RMD) | United States | $36.560B | 27.46 |
Agilent Technologies (A) | United States | $33.258B | 21.68 |
GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.71 |
Terumo (TRUMY) | Japan | $26.680B | 34.65 |
Insulet (PODD) | United States | $21.438B | 84.15 |
Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.37 |
Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.60 |
Baxter (BAX) | United States | $15.713B | 11.73 |
Demant (WILYY) | Denmark | $9.377B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.175B | 21.49 |
Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.54 |
Perrigo (PRGO) | Ireland | $3.664B | 9.29 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Haemonetics (HAE) | United States | $3.367B | 15.34 |
ICU Medical (ICUI) | United States | $3.250B | 23.96 |
Envista Holdings (NVST) | United States | $3.127B | 25.99 |
GN Store Nord (GNNDY) | Denmark | $2.263B | 18.74 |
QuidelOrtho (QDEL) | United States | $1.954B | 13.44 |
LeMaitre Vascular (LMAT) | United States | $1.833B | 40.97 |
AtriCure (ATRC) | United States | $1.565B | 0.00 |
Acuren (TIC) | United States | $1.357B | 0.00 |
Neogen (NEOG) | United States | $1.200B | 15.36 |
AdaptHealth (AHCO) | United States | $1.161B | 11.78 |
Green Thumb Industries (GTBIF) | United States | $1.048B | 23.58 |
BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.970B | 12.40 |
Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
InMode (INMD) | Israel | $0.844B | 8.51 |
Evolus (EOLS) | United States | $0.640B | 0.00 |
CeriBell (CBLL) | United States | $0.624B | 0.00 |
Owens & Minor (OMI) | United States | $0.602B | 4.99 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
Valneva SE (VALN) | France | $0.510B | 0.00 |
Surmodics (SRDX) | United States | $0.417B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
SNDL (SNDL) | Canada | $0.339B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.337B | 12.41 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.329B | 58.50 |
Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
ZimVie (ZIMV) | United States | $0.253B | 11.52 |
Cerus (CERS) | United States | $0.252B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
Quanterix (QTRX) | United States | $0.235B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
Biote (BTMD) | United States | $0.207B | 5.82 |
Brainsway (BWAY) | Israel | $0.206B | 54.50 |
Omeros (OMER) | United States | $0.199B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
Organigram Global (OGI) | Canada | $0.187B | 0.00 |
High Tide (HITI) | Canada | $0.185B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.179B | 14.59 |
Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
Exagen (XGN) | United States | $0.152B | 0.00 |
Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
FitLife Brands (FTLF) | United States | $0.131B | 0.00 |
Jin Medical (ZJYL) | China | $0.107B | 0.00 |
MacroGenics (MGNX) | United States | $0.096B | 0.00 |
Fonar (FONR) | United States | $0.090B | 11.64 |
Veru (VERU) | United States | $0.090B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
Agape ATP (ATPC) | $0.084B | 0.00 | |
TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
InterCure (INCR) | Israel | $0.068B | 0.00 |
Apyx Medical (APYX) | United States | $0.066B | 0.00 |
Zynex (ZYXI) | United States | $0.064B | 0.00 |
ImmuCell (ICCC) | United States | $0.059B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
Nephros (NEPH) | United States | $0.041B | 55.29 |
United-Guardian (UG) | United States | $0.037B | 12.90 |
Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
Safety Shot (SHOT) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
INLIF (INLF) | $0.012B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
Senestech (SNES) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |